Viking Therapeutics, Inc. (VKTX): A Bull Case Theory [Yahoo! Finance]
Viking Therapeutics, Inc. (VKTX)
Last viking therapeutics, inc. earnings: 4/30 04:05 pm
Check Earnings Report
US:NASDAQ Investor Relations:
ir.vikingtherapeutics.com
Company Research
Source: Yahoo! Finance
In this article, we will summarize the bulls' thesis on VKTX. Viking Therapeutics, Inc.'s share was trading at $36.15 as of December 15th. Copyright: dolgachov / 123RF Stock Photo Viking Therapeutics is a clinical-stage biotechnology company focused on metabolic and endocrine disorders, with its investment thesis centered on obesity, diabetes, and NASH. Positioned within the GLP-1/GIP treatment revolution, Viking is one of the few independent biotechs advancing both injectable and oral dual-agonist therapies, making it a strategically scarce asset. Its lead program, VK2735, targets obesity and type-2 diabetes and operates in the same validated receptor class as Eli Lilly's Mounjaro and Novo Nordisk's Wegovy. Phase 2 data demonstrated roughly 14–15% mean weight loss over 13 weeks with strong tolerability, placing the asset squarely in line with current market leaders. Viking is now advancing two pivotal programs, VANQUISH (injectable) and VENTURE-Oral, with the oral formulation r
Show less
Read more
Impact Snapshot
Event Time:
VKTX
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
VKTX alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
VKTX alerts
High impacting Viking Therapeutics, Inc. news events
Weekly update
A roundup of the hottest topics
VKTX
News
- Viking Therapeutics (VKTX): Rethinking Valuation After a Sharp Pullback and Strong Multi-Year Run [Yahoo! Finance]Yahoo! Finance
- 1 Bold Prediction for Viking Therapeutics in 2026 [Yahoo! Finance]Yahoo! Finance
- This is why Viking Therapeutics, Inc. (VKTX) is a Strong Buy on Wall Street [Yahoo! Finance]Yahoo! Finance
- Unusual Bullish Options Activity Could Be A Game Changer For Viking Therapeutics (VKTX) [Yahoo! Finance]Yahoo! Finance
- Viking Therapeutics: Prepping For A Critical 2026 [Seeking Alpha]Seeking Alpha
VKTX
Earnings
- 10/22/25 - Miss
VKTX
Sec Filings
- 11/5/25 - Form SCHEDULE
- 10/28/25 - Form 4
- 10/28/25 - Form 4
- VKTX's page on the SEC website